One of the major risks of gene therapy involves immune system reactions. The body may respond to viral vectors used during treatment, and in some cases severe reactions can occur. Researchers also study issues such as off-target gene modifications, treatment failure, and long-term safety concerns. Recent technological advances have significantly improved the ability to reduce and manage these risks.